Covered recipient · General Payments record
JULIE C MARTIN
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$3,282.04
- Reported across 42 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $762.47 | 8 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $223.56 | 2 |
| SpringWorks Therapeutics, Inc. | $121.80 | 1 |
| E.R. Squibb & Sons, L.L.C. | $121.78 | 1 |
| Amgen Inc. | $102.96 | 1 |
| AVEO Pharmaceuticals, Inc. | $96.38 | 1 |
| Merck Sharp & Dohme Corporation | $91.29 | 1 |
| Janssen Biotech, Inc. | $88.25 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.45 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $102.96 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117620986 | CMS |
| Aveo Pharmaceuticals, Inc. | $96.38 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143494494 | CMS |
| E.R. Squibb & Sons, L.L.C. | $121.78 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101309811 | CMS |
| Incyte Corporation | $99.00 | 04/17/2024 | Education | Undisputed | 01/23/2026 | 1141233081 | CMS |
| Incyte Corporation | $124.56 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141232905 | CMS |
| Janssen Biotech, Inc. | $88.25 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078632766 | CMS |
| Merck Sharp & Dohme LLC | $91.29 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141642366 | CMS |
| SpringWorks Therapeutics, Inc. | $121.80 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1085810266 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.45 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144979582 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.